Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661346 · ClinicalTrials.gov registry record · Phase 2
Esmolol vs. Labetalol in Endoscopic Sinus Surgery
A Phase 2 study of Chronic Sinusitis, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03661346 is a Phase 2 study of Chronic Sinusitis that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 28 participants, below the 193-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03661346, a Phase 2 study of Chronic Sinusitis, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare esmolol and labetalol bleeding and intra-operative visibility scores in functional endoscopic sinus surgery.
Conditions Studied
Interventions
- DRUG Labetalol
- DRUG Esmolol
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03661346
The ClinicalTrials.gov registry entry for NCT03661346 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (85% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Labetalol is the first listed.
NCT03661346 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03661346 about?
NCT03661346 is a clinical study titled "Esmolol vs. Labetalol in Endoscopic Sinus Surgery". The purpose of this study is to compare esmolol and labetalol bleeding and intra-operative visibility scores in functional endoscopic sinus surgery.
What is the current status of trial NCT03661346?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2017-03-01. Estimated completion is 2018-03-30.
What conditions does trial NCT03661346 study?
This clinical trial studies the following conditions: Chronic Sinusitis.
What interventions are being tested in trial NCT03661346?
The interventions under investigation include: Labetalol (DRUG), Esmolol (DRUG).
Who is sponsoring clinical trial NCT03661346?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03661346 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
COMPLETED · Phase 2
-
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
COMPLETED · Phase 2
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
COMPLETED · NA
-
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.